Peer-influenced content. Sources you trust. No registration required. This is HCN.
The New England Journal of Medicine
The recent phase 2 study on atezolizumab shows promising results in inducing sustained responses in advanced ASPS patients.
Oncology, Medical September 11th 2023
Cleveland Clinic Journal of Medicine
This case of Mondor disease highlights the importance of accurate diagnosis and patient education. Learn how to differentiate this benign condition from more serious underlying issues.
Obstetrics & Gynecology September 7th 2023
ACP Internist
Understanding and diagnosing eosinophilic esophagitis (EoE) is becoming increasingly important as ED visits related to the condition are on the rise. Early recognition and referral by primary care physicians can prevent serious complications and improve patient outcomes.
Emergency Medicine September 7th 2023
Practical Neurology
Discover how AOC 1044’s recent FDA orphan drug designation could revolutionize the treatment landscape for Duchenne muscular dystrophy patients with exon 44 mutations. Stay tuned for upcoming results from the EXPLORE44 trial.
Neurology August 30th 2023
Clinical Advances in Hematology & Oncology
Explore the intricacies of diagnosing and treating acral melanoma, a subtype that presents unique challenges but also offers new avenues for targeted therapies and immune modulation.
Oncology, Medical August 28th 2023
This phase 1–2 study of gene therapy in Crigler–Najjar syndrome patients offers promising insights into a novel treatment approach. Explore the detailed findings to understand how this therapy could revolutionize the management of this rare and severe condition.
Gastroenterology August 22nd 2023